Sony patents method to analyze tumors using tissue and blood tests
Sony describes a system that combines direct examinations of tumor tissue with repeated blood tests over time. The method integrates data from both sources to create a comprehensive analysis of the tumor's characteristics.
In the filing’s own words
To provide a method of analyzing a tumor, a system for analyzing a tumor, and a method of generating analyzed data of a tumor that are effective and of high quality. According to the present technology, there is provided a method of analyzing a tumor to acquire information regarding a tumor by using an examination of a tumor tissue and chronological examinations of blood. According to the present technology, there is also provided a method of generating analyzed data of a tumor by using an examination of a tumor tissue and chronological examinations of blood and having the examinations intervene in each other to integrally analyze data from the examinations, thereby generating data regarding the tumor.
What exactly they claim (claim 1)
1. A method of analyzing a tumor, comprising: acquiring information regarding a tumor by using an examination of a tumor tissue and chronological examinations of blood.
Facts
- Company
- Sony (Sony Group Corporation)
- Official title
- METHOD OF ANALYZING TUMOR, SYSTEM FOR ANALYZING TUMOR, AND METHOD OF GENERATING ANALYZED DATA OF TUMOR
- Publication number
- US20260269027A1
- Application number
- 19166275
- Filed
- Mar 13, 2024
- Published
- Sep 10, 2026
- Inventors
- 6
- Claims
- 20
Classified under
G16H 10/40 Physics & computingG16H 50/20 Physics & computingMore from Sony in Health & body
- Sony patents eye surgery display that tracks patient's eye movement Sep 8, 2026
- Sony patents flexible electrode that sticks to skin for health monitoring Sep 15, 2026
- Sony patents robotic arm that adjusts its reach to avoid surgeons Sep 29, 2026
- Sony patents system to predict sleepwalking risk from pre-sleep data Sep 3, 2026
- Sony patents system to link body motion data with user identity Sep 17, 2026
Summaries are simplified from the filing’s own abstract and first claim. A patent filing is not a product announcement.
Patent data and drawings: U.S. Patent and Trademark Office (USPTO). Nebula is not affiliated with or endorsed by the USPTO.